The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Rosalind Franklin Prize for Excellence in Ovarian Cancer Research
The Rosalind Franklin Prize is named for the molecular biologist Dr. Rosalind Franklin, who played a vital role in discovering the structure of DNA. Her life was cut short in 1958 when she died of ovarian cancer at age 37. Throughout her life she was a committed researcher; this award is presented to a senior researcher who continues Franklin’s legacy of excellence.
The Rosalind Franklin Prize for Excellence in Ovarian Cancer Research is a $10,000 annual prize awarded to an individual in recognition of his or her outstanding contributions to basic science, translational, or clinical research in ovarian cancer. Nominees should have a track record of high achievement in the field of ovarian cancer research, as demonstrated by significant contributions to the care of women with gynecologic cancer and to the literature in the field, as well as having obtained significant extramural research funding. The prize rewards past achievement and provides further incentive for an outstanding working scientist to continue to do exceptional research into the causes, prevention, and treatment of ovarian cancer.
Nominees must hold an MD, PhD, or ScD degree, and must hold an academic appointment at a non-profit medical or research institution in the USA.
Deadline: Oct. 14, 2021
Nominations can be made by members of the ovarian cancer research community. To nominate someone for this prize, please submit the following:
1. A completed coversheet (see page two)
2. Letter of nomination (1,500 words or less). In the letter, please describe the nominee’s achievements in the field of ovarian cancer research.
3. CV for the nominee.
Please submit the application material as a single PDF to firstname.lastname@example.org by 11:59pm ET on October 14, 2021.